- Report
- March 2025
- 147 Pages
Global
From €3492EUR$3,999USD£3,023GBP
- Report
- February 2025
- 140 Pages
Global
From €3492EUR$3,999USD£3,023GBP
- Report
- January 2026
- 185 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 197 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 184 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 191 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 195 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 195 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 192 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- August 2025
- 182 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 180 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- January 2026
- 186 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- January 2026
- 185 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- January 2026
- 185 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- January 2026
- 182 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- February 2025
- 182 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- April 2025
- 250 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- April 2025
- 250 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- April 2025
- 250 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- April 2025
- 200 Pages
Global
From €3920EUR$4,490USD£3,394GBP

Hemostasis is a process that helps to stop bleeding and is a part of the larger coagulation and hemostasis testing market. This market includes products and services used to diagnose and monitor bleeding and clotting disorders. Tests used in this market include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen, and platelet aggregation. These tests are used to diagnose and monitor conditions such as hemophilia, thrombocytopenia, and von Willebrand disease.
The coagulation and hemostasis testing market is driven by the increasing prevalence of bleeding and clotting disorders, the growing demand for point-of-care testing, and the development of new technologies. Companies in this market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Alere Inc. Show Less Read more